Let’s talk about something I’ve been seeing more and more, something that’s genuinely changing the landscape of our work. For generations, we’ve sort of mentally filed cancer away as a disease that happens later in life. It was something our parents or grandparents worried about.
But that mental model is getting outdated, fast.
We're seeing a really noticeable, and frankly, sobering, trend: cancer diagnoses in adults under 50. We’re talking about Gen X, millennials, and even the oldest members of Gen Z. These are people in the thick of building careers, starting families, and buying homes. And a cancer diagnosis is the last thing on their radar.
As these individuals come to us seeking life insurance, we, as an industry, have to get smart about this. We can't rely on old assumptions. We need to understand the long-term picture for these clients, and it starts with getting a handle on this new reality.
So, What Cancers Are We Seeing, and What Does "Early-Onset" Even Mean?
First, let's get on the same page. When we say "early adult-onset cancer," we're generally talking about a diagnosis in someone who is 50 years old or younger.
And it’s not just one or two rare types. A major review in Nature Reviews Clinical Oncology pointed out a rising tide across a whole spectrum of cancers. We're seeing more cases of:
- Breast cancer
- Colorectal cancer
- Stomach and esophageal cancer
- Kidney and liver cancer
- Pancreatic cancer
- Prostate cancer
- Thyroid cancer
- And even bone marrow cancers
This isn't just a blip on the radar. It's a significant enough trend that medical guidelines are changing. You’ve probably noticed that the recommended age for a first colonoscopy was lowered from 50 to 45. That’s a direct response to the alarming increase in colorectal cancer among younger adults. It's a clear signal that the medical community is taking this very seriously, and we in the insurance world absolutely have to follow suit.
The Big Question: Why Is This Happening Now?
It’s the question everyone asks, right? If cancer has historically been tied to the natural wear and tear of aging, why are we seeing it in people who are 35 or 45?
The truth is, researchers don't have one single, definitive answer yet. It's complicated.
Sure, some cancers have clear links we can trace. We know certain infections like HPV or HIV can increase risk. We know about genetic predispositions. And we know that exposure to hazardous chemicals or environmental factors, like the burn pits in military zones, can be a direct cause.
But this widespread increase seems to be pointing toward something else, something bigger. The prevailing theory is that it’s connected to major lifestyle shifts that have taken place over the last 50-60 years.
Think about it. Since the mid-20th century, our lives have changed dramatically. We’ve become more sedentary. Obesity rates have skyrocketed. Our diets have shifted to include far more processed foods, full of preservatives and who-knows-what-else. The thinking is that these long-term changes in our environment and habits are impacting our bodies in ways we’re only just beginning to understand.
It's Not Just a Medical History, It's a Life Interrupted
This is the part I think we, as underwriters, need to be most sensitive to. When you get a file for a 38-year-old who had Stage 2 breast cancer, you're not just looking at medical reports. You're looking at the story of a life that was completely derailed.
Think about your 20s and 30s. That’s your building phase. You’re focused on your education, climbing the career ladder, finding a partner, maybe buying a house or starting a family. You feel invincible from a health standpoint. Your biggest worry is supposed to be a mortgage payment, not a chemo schedule.
Receiving a cancer diagnosis at that stage of life is a profound psychological blow. The gap between the life they thought they’d be living and the one they are actually living can be massive and overwhelming. It’s a trauma that doesn’t just disappear when the treatment ends. We have to keep that human element front and center.
The Underwriting Playbook: What We Need to Look For
Okay, let's get down to brass tacks. When a case involving early-onset cancer lands on your desk, it requires a careful and thorough approach. These cancers often tend to be more aggressive than their later-life counterparts.
Here’s a checklist of what you absolutely need to dig into to get a complete picture of the risk:
- The Basics of the Diagnosis: What was the exact type, stage, and grade of the cancer? What was the person's age when they were diagnosed?
- Cancer-Specific Details: We need the nitty-gritty. For prostate cancer, what was the PSA and Gleason score? For breast cancer, were the estrogen receptors positive or negative? These details tell a huge part of the story.
- Genetics and Family History: Was any genetic testing done? Is there a family history of this or other cancers, and at what ages?
- The Treatment Story: What was the full treatment plan—surgery, chemo, radiation, immunotherapy? And, critically, when did it end?
- Recurrence and Follow-Up: Has the cancer ever come back? Just as important, what is their follow-up care plan? Are they diligently getting the recommended screenings and check-ups? This shows commitment to their ongoing health.
- The Whole Health Picture: What else is going on? We need to know about any other health conditions. What are they doing now to stay healthy? Are they active? Do they eat well? Have they quit smoking or reduced their drinking?
- The Lingering Effects of Treatment: This is a huge one that can be easily overlooked. Cancer treatment is brutal, and it can leave lasting damage. We have to look for potential cardiac issues from chemo or radiation. Has it caused other problems like lymphedema, osteoporosis, or chronic fatigue? Sometimes the "cure" creates its own set of long-term risks.
- The Mental Health Component: As we talked about, the psychological toll is immense. If there are diagnoses like anxiety or depression in the file, we need to understand them in the context of their cancer journey. The chronic stress of being a survivor, especially one dealing with long-term side effects, is a real and significant factor.
Assessing these cases isn't just about checking boxes. It's about piecing together a complete puzzle. We have to be diligent, but we also have to be human. We're evaluating a person who has been through one of the toughest fights of their life, and our work should reflect that understanding and care. This trend isn't going away, so the better we get at navigating these complexities, the better we'll serve our clients and our companies.
